Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Medical Professionals Reference (MPR)

FDA Warns of Increased Side Effects, Death Risk with Duvelisib

Hematology/Oncology July 5th 2022

Clinical Advances in Hematology & Oncology

The Emerging Role of Pirtobrutinib in Chronic Lymphocytic Leukemia

Hematology/Oncology May 18th 2022

Blood

Oral Azacitidine Prolongs Survival of Patients with AML in Remission Independently of Measurable Residual Disease Status

Hematology/Oncology May 18th 2022

Cancer Therapy Advisor

Moderna COVID-19 Vaccine May Be More Effective in CLL Patients

Hematology/Oncology April 12th 2022

JAMA Network

Decade-Long CLL Remission After CAR T-Cell Therapy Reported

Hematology/Oncology March 29th 2022

Blood Advances

Differential Impact of IDH1/2 Mutational Subclasses on Outcome in Adult AML: Results from a Large Multicenter Study

Hematology/Oncology March 15th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form